Katrin Sak Selected Research

Neoplasms (Cancer)

12/2023	Nanoformulations of quercetin for controlled delivery: a review of preclinical anticancer studies.
3/2023	Immunotherapeutics in lung cancers: from mechanistic insight to clinical implications and synergistic perspectives.
2/2023	Apoptotic Mechanisms of Quercetin in Liver Cancer: Recent Trends and Advancements.
2/2023	Autophagy Induction by Scutellaria Flavones in Cancer: Recent Advances.
1/2023	Chemopreventive mechanisms of amentoflavone: recent trends and advancements.
1/2023	Natural flavonoids exhibit potent anticancer activity by targeting microRNAs in cancer: A signature step hinting towards clinical perfection.
1/2023	Ginnalin A and hamamelitannin: the unique gallotannins with promising anti-carcinogenic potential.
1/2023	Molecular mechanisms behind ROS regulation in cancer: A balancing act between augmented tumorigenesis and cell apoptosis.
1/2023	Application of curcumin nanoformulations to target folic acid receptor in cancer: Recent trends and advances.
12/2022	Cucurbitacins as Potent Chemo-Preventive Agents: Mechanistic Insight and Recent Trends.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katrin Sak Research Topics

Disease

53	Neoplasms (Cancer) 12/2023 - 01/2012
9	Carcinogenesis 11/2022 - 01/2016
8	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2015
7	Inflammation (Inflammations) 09/2022 - 01/2018
4	Carcinoma (Carcinomatosis) 09/2022 - 01/2014
4	Prostatic Neoplasms (Prostate Cancer) 04/2020 - 07/2014
3	Lymphoma (Lymphomas) 09/2022 - 08/2018
3	Breast Neoplasms (Breast Cancer) 09/2022 - 01/2017
3	Hematologic Neoplasms (Hematological Malignancy) 08/2018 - 07/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2023 - 09/2022
2	Liver Neoplasms (Liver Cancer) 02/2023 - 02/2018
2	COVID-19 01/2023 - 01/2021
2	Multiple Myeloma 09/2022 - 01/2022
2	Hepatocellular Carcinoma (Hepatoma) 09/2022 - 04/2020
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2014
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 08/2018
2	Leukemia 02/2017 - 01/2015
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2014 - 01/2014
2	Astrocytoma (Pilocytic Astrocytoma) 09/2012 - 07/2005
1	Pain (Aches) 12/2022

Drug/Important Bio-Agent (IBA)

18	FlavonoidsIBA 01/2023 - 01/2014
11	PhytochemicalsIBA 01/2022 - 01/2012
10	QuercetinIBA 12/2023 - 01/2014
7	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2005
6	AntioxidantsIBA 12/2023 - 03/2016
6	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 01/2014
5	PolyphenolsIBA 01/2023 - 07/2014
4	LuteolinIBA 01/2023 - 07/2014
3	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 02/2023 - 01/2022
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 09/2012
3	CurcuminIBA 01/2023 - 03/2016
3	kaempferolIBA 01/2022 - 07/2014
3	ApigeninIBA 01/2022 - 07/2014
3	fisetinIBA 01/2019 - 09/2016
2	baicaleinIBA 02/2023 - 10/2020
2	FlavonesIBA 02/2023 - 01/2017
2	GenisteinIBA 01/2023 - 01/2019
2	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2021
2	Silybin (Lagosa)IBA 01/2023 - 01/2021
2	LipidsIBA 01/2023 - 01/2020
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2023 - 01/2022
2	Transcription Factors (Transcription Factor)IBA 09/2022 - 04/2020
2	TOR Serine-Threonine KinasesIBA 01/2022 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 11/2019
2	HesperidinIBA 01/2022 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2020
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2022 - 11/2019
2	Emodin (Archin)IBA 01/2022 - 06/2021
2	Mitogen-Activated Protein KinasesIBA 01/2021 - 11/2019
2	Therapeutic UsesIBA 01/2021 - 01/2017
2	VaccinesIBA 01/2021 - 01/2020
2	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 11/2019
2	3-hydroxyflavoneIBA 02/2018 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2016
2	FlavonolsIBA 01/2017 - 09/2016
1	Liposomes (Liposome)IBA 12/2023
1	PolymersIBA 12/2023
1	MicellesIBA 12/2023
1	GelsIBA 12/2023
1	GoldIBA 12/2023
1	Lipid NanoparticlesIBA 12/2023
1	CyclodextrinsIBA 12/2023
1	CytokinesIBA 03/2023
1	pembrolizumabIBA 03/2023
1	IpilimumabIBA 03/2023
1	Immune Checkpoint InhibitorsIBA 03/2023
1	AntibodiesIBA 03/2023
1	Monoclonal AntibodiesIBA 03/2023
1	cemiplimabIBA 03/2023
1	B7-H1 AntigenIBA 03/2023
1	atezolizumabIBA 03/2023
1	baicalinIBA 02/2023
1	wogoninIBA 02/2023
1	scutellarinIBA 02/2023
1	scutellareinIBA 02/2023
1	ginnalin AIBA 01/2023
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2023
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 01/2023
1	LigandsIBA 01/2023
1	cyanidinIBA 01/2023
1	CucurbitacinsIBA 12/2022
1	PhloretinIBA 12/2022
1	EquolIBA 11/2022
1	ferulic acid (sodium ferulate)IBA 11/2022
1	phenolic acidIBA 11/2022
1	Untranslated RNA (Noncoding RNA)IBA 09/2022
1	Bortezomib (Velcade)FDA Link 01/2022
1	Proteasome InhibitorsIBA 01/2022
1	Cyclin-Dependent Kinase 2IBA 01/2022
1	Propolis (Bee Bread)IBA 01/2022
1	ampelopsinIBA 01/2022
1	ixazomibIBA 01/2022
1	dutogliptinIBA 01/2022
1	Gallic AcidIBA 01/2022
1	galanginIBA 01/2022
1	dihydromyricetinIBA 01/2022

Therapy/Procedure

15	Therapeutics 01/2023 - 01/2012
5	Drug Therapy (Chemotherapy) 01/2022 - 01/2012
3	Immunotherapy 01/2022 - 01/2021
3	Radiotherapy 01/2022 - 09/2012